Korro Bio Inc (KRRO)

02:42 AM

HC Wainwright Reaffirms Buy Rating for Korro Bio (NASDAQ:KRRO) - Defense World

02:42 AM

Nov 23, 2024

Korro Bio (NASDAQ:KRRO) Trading 9.3% HigherStill a Buy? - MarketBeat

Nov 23, 2024

Nov 22, 2024

Korro Bio (NASDAQ:KRRO) Receives Buy Rating from HC Wainwright - MarketBeat

Nov 22, 2024

Nov 21, 2024

Korro to Participate in Upcoming Investor Conferences - The Manila Times

Nov 21, 2024

Nov 21, 2024

Korro Bio CEO to Present at Major Healthcare Conferences in December | KRRO Stock News - StockTitan

Nov 21, 2024

Nov 21, 2024

Korro Receives Australian HREC Approval and CTN Clearance to Initiate Phase 1/2a Clinical Study (REWRITE) of KRRO-110 for Alpha-1 Antitrypsin Deficiency - The Manila Times

Nov 21, 2024

Nov 21, 2024

Korro Bio Gains Approval for Phase 1/2a AATD Treatment Trial, Shows Strong Preclinical Data | KRRO Stock News - StockTitan

Nov 21, 2024

Nov 18, 2024

Jones Trading bullish on Korro Bio stock amid RNA editing and AATD prospects - Investing.com

Nov 18, 2024

Nov 18, 2024

Jones Trading Initiates Coverage of Korro Bio (KRRO) with Buy Recommendation - MSN

Nov 18, 2024

Nov 18, 2024

Korro Bio FY2024 EPS Forecast Increased by HC Wainwright - MarketBeat

Nov 18, 2024

Nov 18, 2024

William Blair Has Positive View of Korro Bio FY2024 Earnings - MarketBeat

Nov 18, 2024

Nov 15, 2024

Korro Bio, Inc. (NASDAQ:KRRO) Given Consensus Rating of "Buy" by Analysts - MarketBeat

Nov 15, 2024

Nov 14, 2024

Eventide Asset Management's Strategic Reduction in Korro Bio Inc Holdings - GuruFocus.com

Nov 14, 2024

Nov 14, 2024

Deep Track Capital, LP's Strategic Acquisition of Korro Bio Inc Shares - GuruFocus.com

Nov 14, 2024

Nov 14, 2024

Korro to Present at the Jefferies London Healthcare Conference - The Manila Times

Nov 14, 2024

Nov 14, 2024

Korro Bio to Present RNA-Editing Breakthroughs at Jefferies London Healthcare Conference | KRRO Stock News - StockTitan

Nov 14, 2024

Nov 13, 2024

Korro Bio’s Progress and Financial Updates - TipRanks

Nov 13, 2024

Nov 13, 2024

Korro Bio's SWOT analysis: RNA editing pioneer's stock poised for growth - Investing.com

Nov 13, 2024

Nov 13, 2024

William Blair Reiterates "Outperform" Rating for Korro Bio (NASDAQ:KRRO) - MarketBeat

Nov 13, 2024

Nov 13, 2024

Korro Reports Third Quarter 2024 Financial Results and Provides Business Updates - The Manila Times

Nov 13, 2024

Nov 13, 2024

FMR LLC Reduces Stake in Korro Bio Inc - GuruFocus.com

Nov 13, 2024

Nov 12, 2024

Korro Bio CFO Vineet Agarwal sells $56,000 in stock - Investing.com

Nov 12, 2024

Nov 12, 2024

Korro Bio CFO Vineet Agarwal sells $56,000 in stock By Investing.com - Investing.com UK

Nov 12, 2024

Nov 12, 2024

Korro Bio Partners with Novo Nordisk, Reports $169M Cash Position Despite Widening Losses | KRRO Stock News - StockTitan

Nov 12, 2024

Nov 08, 2024

4 Biotech Stocks With AI, Machine Learning Prowess - Investing.com

Nov 08, 2024

Nov 07, 2024

Korro Bio (NASDAQ:KRRO) Stock Price Up 10.9%Here's What Happened - MarketBeat

Nov 07, 2024

Nov 05, 2024

Korro Bio files in Australia to begin first-in-human study of KRRO-110 for AATD - BioWorld Online

Nov 05, 2024

Nov 04, 2024

Korro Bio (NASDAQ:KRRO) Shares Gap DownHere's Why - MarketBeat

Nov 04, 2024

Nov 04, 2024

Korro Announces Regulatory Filing for Initiation of KRRO-110 First-In-Human Study and Formation of Clinical Advisory Board - The Manila Times

Nov 04, 2024

Nov 04, 2024

Korro Bio, Inc. Announces Submission to Bellberry HREC for Phase 1/2 Clinical Study of KRRO-110 for AATD - Marketscreener.com

Nov 04, 2024

Oct 28, 2024

Korro Bio (NASDAQ:KRRO) Trading Down 5.1%Time to Sell? - MarketBeat

Oct 28, 2024

Oct 25, 2024

Korro Bio's SWOT analysis: RNA editing pioneer's stock poised for clinical leap - Investing.com India

Oct 25, 2024

Oct 24, 2024

Korro Bio's SWOT analysis: RNA editing pioneer's stock poised for clinical leap By Investing.com - Investing.com South Africa

Oct 24, 2024

Oct 23, 2024

Korro Bio (NASDAQ:KRRO) Sees Large Volume IncreaseStill a Buy? - MarketBeat

Oct 23, 2024

Oct 23, 2024

Korro Bio (NASDAQ:KRRO) Coverage Initiated at Raymond James - Defense World

Oct 23, 2024

Oct 22, 2024

RBC lifts Korro Bio stock target on positive RNA editing outlook - Investing.com Australia

Oct 22, 2024

Oct 22, 2024

Raymond James Initiates Coverage of Korro Bio (KRRO) with Strong Buy Recommendation - MSN

Oct 22, 2024

Oct 21, 2024

Korro Bio price target raised to $105 from $95 at RBC Capital - TipRanks

Oct 21, 2024

Oct 21, 2024

RBC lifts Korro Bio stock target on positive RNA editing outlook By Investing.com - Investing.com South Africa

Oct 21, 2024

Oct 21, 2024

Royal Bank of Canada Boosts Korro Bio (NASDAQ:KRRO) Price Target to $105.00 - MarketBeat

Oct 21, 2024

Oct 21, 2024

Korro Bio initiated with a Strong Buy at Raymond James - TipRanks

Oct 21, 2024

Oct 21, 2024

Korro Bio, Inc. (NASDAQ:KRRO) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat

Oct 21, 2024

Oct 21, 2024

Korro Bio Is Lagging Wave Life Sciences In RNA Editing. Why It Could Ultimately Lead The Space. - Investor's Business Daily

Oct 21, 2024

Oct 19, 2024

Korro bio CFO Vineet Agarwal sells $799,526 in stock - Investing.com India

Oct 19, 2024

Oct 18, 2024

Insider Selling: Korro Bio, Inc. (NASDAQ:KRRO) CFO Sells 10,216 Shares of Stock - MarketBeat

Oct 18, 2024

Oct 18, 2024

Korro bio CFO Vineet Agarwal sells $799,526 in stock By Investing.com - Investing.com Australia

Oct 18, 2024

Oct 18, 2024

Korro Bio shares target lifted, buy rating on RNA editing potential - Investing.com

Oct 18, 2024

Oct 18, 2024

Korro Bio (NASDAQ:KRRO) Trading Down 4.1%Should You Sell? - MarketBeat

Oct 18, 2024

Oct 18, 2024

HC Wainwright Increases Korro Bio (NASDAQ:KRRO) Price Target to $115.00 - MarketBeat

Oct 18, 2024